Salesforce.com, inc. (NYSE:CRM) stock is 0.2% higher at $270.90 at last glance. Shares of the blue-chip
cloud technology stock recently suffered a bear gap on the charts that pulled it away form its March 1, record high of $318.72. The equity has shed 11.6% over the last month and is now closing in on its year-to-date breakeven mark, though a historically bullish trendline could help turn things around.
Specifically, Salesforce.com stock just came within one standard deviation of its 126-day moving average, after months spent above this trendline. According to data from Schaeffer's Senior Quantitative Analyst Rocky White, one similar signal was seen over the last three years. CRM enjoyed a positive return one month later after that instance, snagging a 5.5% gain. From its current perch, a comparable move would place the security at nearly $286.
The stock's 50-day put/call volume ratio of 0.91 at the International Securities Exchange (ISE), Cboe Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) is in the elevated 85th percentile of its annual range. This suggests a very healthy appetite for long puts of late, and an unwinding of this pessimism could help the stock move higher.
The stock's "oversold" 14-day relative strength index (RSI) of 23.9 points to near-term tailwinds. Options are affordable at the moment too, per Salesforce.com stock's Schaeffer's Volatility Index (SVI) of 29% that ranks in the 20th percentile.
Before you make your next trade, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis.
Our team has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and none of the big name stocks were on the list.
They believe these five stocks are the five best companies for investors to buy now...
See The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report